Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has recently approved four veterinary generics.
Dutch company Le Vet Pharma has secured decentralized European approval for its Tranquigel (acepromazine) sedative for dogs and horses.
The European Group for Generic Veterinary Products (EGGVP) has re-elected its Spanish chair Dolores Caínzos to continue leading the organization for the next three years.
Despite adding 52 new companies since 2006, the growth of the Kansas City Animal Health Corridor (KCAHC) shows no sign of abating.
Aurora Pharmaceutical has received US authorization for a reproductive product in horses.
The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has approved Virbac Japan's EasOtic (hydrocortisone aceponate, miconazole nitrate, gentamicin sulphate) to treat infectious external otitis in dogs.
The merger between Belgian firm Ecuphar and UK business Animalcare has closed.
Slovenian generics specialist Krka recorded another fall in sales for its animal health products during the second quarter of 2017.
Dutch firm Le Vet Pharma has gained three recent approvals in Europe as it continues to ramp up its portfolio of generics in its home continent.
Virbac has enlarged its portfolio of pet generics in the US after receiving FDA approval for a companion animal anesthetic.
A strong performance from its North American operations has helped propel the UK's leading animal health company Dechra Pharmaceuticals to a strong 28% growth in revenues for the year ended June 30.
US firm Zander Therapeutics has boosted its level of industry know-how by hiring Brian Devine to head its business advisory board.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.